Decoding Organ-Specific Vulnerability to Triptolide Toxicity: A Systems Toxicology Approach Targeting Glucose Metabolism
Related Experiment Video
Updated: May 6, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
Published on: March 4, 2021
1Clinical Pharmacy Department, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, 350025, PR China.
Introduction/Objective:
Triptolide, a diterpenoid epoxide derived from Tripterygium wilfordii Hook F, exhibits potent therapeutic activities but is clinically limited by severe multiorgan toxicity, the mechanisms of which remain poorly understood. This study aimed to elucidate these mechanisms using an integrative computational framework.
Methods:
We employed a multi-step computational approach combining network pharmacology, Mendelian randomization (MR), molecular docking, molecular dynamics simulations, and single- cell RNA sequencing analysis to systematically identify and evaluate toxicity pathways.
Results:
Network analysis identified 29 common toxicity targets across hepatic, renal, cardiac, and reproductive systems. Functional enrichment revealed that disruption of glycolysis and the pentose phosphate pathway is a central mechanism. This supports a dual toxicity model involving: (1) a "cellular energy crisis" due to impaired ATP production (via enzymes such as GCK), and (2) an "oxidative redox imbalance" resulting from NADPH depletion (via enzymes such as RPIA). MR analysis further indicated potential causal links between these targets and organ damage. Molecular docking and dynamics simulations showed stable, high-affinity complexes with these enzymes (binding energies: -7.0 to -9.1 kcal/mol), providing a structural basis for the interactions. Single-cell RNA sequencing analysis highlighted organ-specific vulnerability related to the cell-type-specific expression of these target enzymes.
Discussion:
Triptolide-induced disruption of glucose homeostasis via direct enzyme interactions may underlie its multi-organ toxicity. This integrative framework bridges molecular-level interactions and organ pathology, providing a comprehensive strategy to dissect complex toxicity mechanisms.
Conclusion:
Our findings suggest that triptolide's multi-organ toxicity is mechanistically rooted in the disruption of glucose metabolism, driven by interactions with core metabolic enzymes. This integrative computational study offers novel insights into pan-organ toxicity and provides a potential basis for designing safer triptolide analogues.
Insights
Triptolide causes severe organ damage by disrupting glucose metabolism, leading to cellular energy crisis and oxidative imbalance. This study reveals key enzyme interactions underlying its multi-organ toxicity.
Area of Science:
- Pharmacology
- Computational Biology
- Toxicology
Background:
- Triptolide, a natural compound, has therapeutic potential but causes severe multi-organ toxicity.
- The precise mechanisms driving triptolide-induced toxicity are not fully understood.
- Understanding these mechanisms is crucial for clinical application and drug development.
Purpose of the Study:
- To elucidate the molecular mechanisms of triptolide-induced multi-organ toxicity.
- To utilize an integrative computational framework to identify toxicity pathways.
- To provide a basis for developing safer triptolide analogs.
Main Methods:
- Network pharmacology to identify toxicity targets.
- Mendelian randomization (MR) to assess causal links.
- Molecular docking and dynamics simulations for structural analysis.
- Single-cell RNA sequencing for cell-type-specific vulnerability.
Main Results:
- Identified 29 common toxicity targets across hepatic, renal, cardiac, and reproductive systems.
- Disruption of glycolysis and pentose phosphate pathways identified as a central mechanism.
- Dual toxicity model proposed: cellular energy crisis and oxidative redox imbalance.
- Confirmed stable interactions between triptolide and key metabolic enzymes (e.g., GCK, RPIA).
Conclusions:
- Triptolide-induced disruption of glucose homeostasis via direct enzyme interactions underlies its multi-organ toxicity.
- Integrative computational framework successfully bridged molecular interactions and organ pathology.
- Findings offer insights into pan-organ toxicity and guide the design of safer triptolide analogs.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drug Toxicity: Dose-Dependent Reactions
Pharmacogenomics: Identification of New Drug Targets
Drug Toxicity: Risk factors
Drug Toxicity: Overview

